Stocks › ATRC
AtriCure, Inc.
ATRC·Nasdaq·
United States·USD
$55.39
+1.28 (+2.37%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
ATRC
AtriCure, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ATRCS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of ATRC by members of U.S. Congress · 13 on record · 3 in the last 12 months
Whale Activity
Position changes in ATRC reported for 2026-09-30 by 330 institutional filers
- Increased81
- New75
- Held29
- Decreased85
- Closed43
- No prior filing17
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 7.9M | $446.4M | increased |
| WELLINGTON MANAGEMENT GROUP LLP | 4.1M | $231.3M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.6M | $203.8M | increased |
| ALLIANCEBERNSTEIN L.P. | 2.9M | $164.5M | increased |
| Hood River Capital Management LLC | 2.8M | $159.8M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | $123.3M | increased |
| STATE STREET CORP | 2.1M | $119.6M | increased |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $73.2M | decreased |
| GOLDMAN SACHS GROUP INC | 1.1M | $62.3M | decreased |
| DIMENSIONAL FUND ADVISORS LP | 1.0M | $57.4M | decreased |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 939.6K | $52.8M | decreased |
| BANK OF AMERICA CORP /DE/ | 930.3K | $52.3M | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by ATRC insiders, by quarter · Form 4
Recent Insider Transactions
1,359 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| JOHNSON B KRISTINEDirector · Director | Sale | −2,452 | $58.48 | $143K | Nov 6, 2026 | Form 4 ↗ |
| Privitera SalvatoreChief Technical Officer | Sale | −8,404 | $65.00 | $546K | Nov 4, 2026 | Form 4 ↗ |
| Privitera SalvatoreChief Technical Officer | Sale | −4,519 | $60.00 | $271K | Sep 23, 2026 | Form 4 ↗ |
| GROVES REGINA EDirector | Sale | −5,313 | $54.22 | $288K | Sep 11, 2026 | Form 4 ↗ |
| Privitera SalvatoreChief Technical Officer | Sale | −3,657 | $55.00 | $201K | Sep 8, 2026 | Form 4 ↗ |
| Privitera SalvatoreChief Technical Officer | Sale | −7,763 | $52.50 | $408K | Sep 2, 2026 | Form 4 ↗ |
| Dahlquist Karl S.Chief Legal Officer | Sale | −9,370 | $48.89 | $458K | Aug 24, 2026 | Form 4 ↗ |
| Yuen MaggieDirector | Sale | −3,500 | $38.42 | $134K | Aug 5, 2026 | Form 4 ↗ |
| Prange KarenDirector | Sale | −3,564 | $38.80 | $138K | Aug 5, 2026 | Form 4 ↗ |
| CARREL MICHAEL HPresident, CEO, & Director · Director | Gift | −4,000 | $0.00 | $0 | Jul 30, 2026 | Form 4 ↗ |
| CARREL MICHAEL HPresident, CEO, & Director · Director | Gift | −700 | $0.00 | $0 | Jul 30, 2026 | Form 4 ↗ |
| Noznesky Justin JChief Mktg & Strategy Officer | Sale | −6,182 | $38.80 | $240K | Jul 29, 2026 | Form 4 ↗ |
| Doraiswamy VinayakChief Scientific Officer | Sale | −6,000 | $38.88 | $233K | Jul 28, 2026 | Form 4 ↗ |
| WEHRWEIN SVENDirector | Sale | −25.0K | $37.84 | $946K | Jul 28, 2026 | Form 4 ↗ |
| WEHRWEIN SVENDirector | Option exercise | +25.0K | $19.95 | $499K | Jul 28, 2026 | Form 4 ↗ |
| Doraiswamy VinayakChief Scientific Officer | Grant / award | +636 | $23.78 | $15K | Jun 30, 2026 | Form 4 ↗ |
| Dahlquist Karl S.Chief Legal Officer | Grant / award | +636 | $23.78 | $15K | Jun 30, 2026 | Form 4 ↗ |
| Seith Douglas JChief Operating Officer | Grant / award | +527 | $23.78 | $13K | Jun 30, 2026 | Form 4 ↗ |
| Privitera SalvatoreChief Technical Officer | Grant / award | +636 | $23.78 | $15K | Jun 30, 2026 | Form 4 ↗ |
| CARREL MICHAEL HPresident, CEO, & Director · Director | Grant / award | +636 | $23.78 | $15K | Jun 30, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding ATRC · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Nomura Small Cap Core Fund Delaware Group Equity Funds V | 1.4M | $66.6M | 1.27% | Aug 31, 2026 |
| Hood River Small-Cap Growth Fund Manager Directed Portfolios | 1.5M | $42.7M | 0.64% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.5M | $42.5M | 0.00% | Jun 30, 2026 |
| AB DISCOVERY GROWTH FUND, INC. | 742.3K | $41.7M | 1.67% | Sep 30, 2026 |
| AB Small Cap Growth Portfolio AB CAP FUND, INC. | 713.0K | $40.1M | 1.57% | Sep 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 1.3M | $36.3M | 0.04% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 1.1M | $30.8M | 0.02% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 545.4K | $20.6M | 0.06% | Jul 31, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 632.9K | $17.7M | 0.04% | Jun 30, 2026 |
| MFS New Discovery Fund MFS SERIES TRUST I | 341.9K | $16.5M | 0.77% | Aug 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list ATRC's shares (CUSIP 04963C209), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Wellington Management Company LLPSCHEDULE 13G/A · passive (13G) · 4.1M shares6.8%
Nov 16, 2026 · ↗ - Wellington Investment Advisors Holdings LLPSCHEDULE 13G/A · passive (13G) · 4.1M shares8.1%
Nov 16, 2026 · ↗ - Wellington Group Holdings LLPSCHEDULE 13G/A · passive (13G) · 4.1M shares8.1%
Nov 16, 2026 · ↗ - Wellington Management Group LLPSCHEDULE 13G/A · passive (13G) · 4.1M shares8.1%
Nov 16, 2026 · ↗ - Vanguard Portfolio ManagementSCHEDULE 13G/A · passive (13G) · 3.7M shares7.2%
Oct 30, 2026 · ↗ - BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 7.8M shares15.4%
Oct 5, 2026 · ↗ - AllianceBernstein L.P.SCHEDULE 13G/A · passive (13G) · 2.8M shares5.5%
Aug 14, 2026 · ↗ - Wellington Management Company LLPSCHEDULE 13G/A · passive (13G) · 3.4M shares5.5%
May 15, 2026 · ↗ - Wellington Investment Advisors Holdings LLPSCHEDULE 13G/A · passive (13G) · 3.4M shares6.8%
May 15, 2026 · ↗ - Wellington Group Holdings LLPSCHEDULE 13G/A · passive (13G) · 3.4M shares6.8%
May 15, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming atricure as client
Government Contracts
Federal awards to atricure · USAspending
$77KAwarded · 3 contracts on record
U.S. Patents
Recent USPTO applications naming AtriCure, Inc.
No USPTO patent applications found for AtriCure, Inc..
Annual Financials
From ATRC's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $534.5M | $465.3M | $399.2M | $330.4M | $274.3M |
| Operating income | -$9.4M | -$40.0M | -$26.7M | -$42.7M | $55.2M |
| Net income | -$11.4M | -$44.7M | -$30.4M | -$46.5M | $50.2M |
| Diluted EPS | -$0.24 | -$0.95 | -$0.66 | -$1.02 | $1.09 |
| Operating cash flow | $57.3M | $12.2M | $4.5M | -$22.1M | -$13.8M |
| Cash and equivalents | $167.4M | $122.7M | $84.3M | $58.1M | $43.7M |
| Total assets | $654.2M | $609.3M | $613.9M | $585.4M | $615.3M |
| Total liabilities | $162.2M | $148.4M | $147.8M | $128.7M | $131.6M |
| Shareholders' equity | $491.9M | $461.0M | $466.2M | $456.8M | $483.8M |
As AtriCure, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 19, 2026 ↗
Stock Splits
Every split and reverse split in the price history
No stock splits in ATRC's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 9.01Results of operationsNov 3, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 23, 2026
EDGAR ↗ - 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteMay 19, 2026
EDGAR ↗ - 8-K/A · Items 2.02, 9.01Results of operationsMay 6, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 5, 2026
EDGAR ↗
About AtriCure, Inc.
From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersMASON, OH
IncorporatedDE
SEC CIK0001323885 ↗


